Skip to content
To the full analysis

Asymchem Laboratories (Tianjin) stock: balance sheet and debt

002821.SZ
$22.90Closing price of 12 Nov 2026MEQIRI Score 64 out of 100

Asymchem Laboratories (Tianjin) has a debt to equity ratio of 0.01 and an interest coverage of over 100x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.01
Interest coverage
> 100x
Current ratio
5.85
Cash & equivalents
$1.12B
Total assets
$3.04B
Equity ratio
87%
Goodwill
$21.92M
Plus intangible assets of $63.25M
Net debt
−$1.08B
More cash than debt

Total assets and equity ratio

How large the balance sheet of Asymchem Laboratories (Tianjin) Co., Ltd. is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2011$120.03M$4.01Mnot split out63.4%−$16.86M
2012$124.17M$3.91Mnot split out73.4%−$2.27M
2013$136.95M$7.9Mnot split out75.1%−$5.24M
2014$158.69M$8.12Mnot split out74.2%−$11.18M
2015$190.68M$9.78Mnot split out73.7%−$32.09M
2016$366.65M$9.65Mnot split out75.0%−$134.6M
2017$395.49M$10Mnot split out81.7%−$125.86M
2018$477.69M$17.63Mnot split out78.8%−$95.54M
2019$563.68M$18.27Mnot split out81.0%−$65.27M
2020$1.08B$49.32M$6.48M83.4%−$313.23M
2021$2.27B$78.03M$21.92M83.2%−$931.94M
2022$2.74B$92.89M$21.92M86.1%−$1.1B
2023$2.96B$91.75M$21.92M88.6%−$1.33B
2024$2.89B$86.43M$21.92M87.4%−$1.06B
2025$3.04B$85.18M$21.92M87.0%−$1.08B

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt. In years without separate goodwill, the table shows the sum of goodwill and intangible assets, because the data do not list goodwill separately there.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2011$26.31M$76.06M$9.45M0.12
2012$10.07M$84.26M$7.8M0.09
2013$12.72M$94.45M$7.49M0.07
2014$21.65M$111.81M$10.47M0.09
2015$44.09M$132.15M$12M0.09
2016$162.5M$263.09M$27.89M0.1
2017$125.86M$308.57M$00
2018$95.54M$376.5M$00
2019$65.27M$456.72M$00
2020$318.62M$898.25M$5.39M0.01
2021$995.11M$1.89B$63.18M0.03
2022$1.12B$2.35B$16.47M0.01
2023$1.35B$2.62B$17.8M0.01
2024$1.1B$2.53B$42.37M0.02
2025$1.12B$2.64B$38.46M0.01

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 13 Dec 2024)
  • Valuation signal Overvalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy